Merck’s Keytruda scores in frontline lung cancer yet again
08:48 EDT 10 Apr 2018 |
PMLIVE
Drug improved overall survival as a monotherapy, which rival BMS’ Opdivo was unable to show
Original Article: Merck’s Keytruda scores in frontline lung cancer yet again
More From BioPortfolio on "Merck’s Keytruda scores in frontline lung cancer yet again"